
SurgePays, Inc.
SurgePays, Inc. (SURG) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
surg · stock forecast · 6 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$10.00
Consensus
$10.00
+1900.0% upside
Low
$10.00
Median: $10 · Last Close: $0.50
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.49 | ↓ 2.20% |
1-day model range: $0.48–$0.5. Peak: $0.5 (-2.20%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · SURG · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-17 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-12-22 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-10-03 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-06-16 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-04-22 | Ascendiant Capital | Maintains | Buy→Buy |
| 2024-12-16 | Ascendiant Capital | Maintains | Buy→Buy |
| 2024-06-06 | Ascendiant Capital | Maintains | Buy→Buy |
| 2024-04-01 | Ascendiant Capital | Maintains | Buy→Buy |
| 2024-03-13 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2022-02-28 | Maxim Group | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on SurgePays, Inc. (SURG) stock. Of the recent 17 rating actions, 2 were upgrades and 2 were downgrades. 6 analysts currently cover SURG.
Analyst Recommendation Trends
SURG analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$113M
↑ 76.6% YoY
Revenue Next Year
$60M
↓ 47.3% YoY
EPS This Year
$-0.09
EPS Next Year
$-1.59
↑ 1609.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast SURG EPS of $-0.09 for the current fiscal year, based on estimates from 1 analysts. The SURG revenue forecast is $113M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The SURG stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SURG price target is $10.00 (+1900.0% upside), with an analyst consensus of Buy.
The SURG short-term stock prediction for tomorrow is $0.49 (-2.20%). The SURG stock prediction for 2030 projects a range of $0–$0.
SurgePays, Inc. trades on NASDAQ under the ticker SURG. The SURG stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.
Frequently asked questions
SURG forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month SURG price target is $10.00, with a high forecast of $10.00 and a low of $10.00. The median price target is shown in the chart above when available. This implies +1900.0% potential upside from the current price of $0.50.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.